Bioavailability emerges as a key nutritional driver, says Frutarom Natural Solutions Chief

04 Jul 2018 --- The demand for natural, sustainable and integrated solutions, as well as growing calls for expressing bioavailability are all key drivers for today’s health and nutrition products, Frutarom’s President of Natural Solutions, Yoni Glickman has said. The business unit, which offers Flavor & Color, Food Protection and Health Benefits, accounts for about 25 percent of Frutarom’s turnover. An integrated cognitive health platform will be just one of the target areas for growth for the business, in the run-up to Frutarom’s US$7.1 billion acquisition by International Flavors & Fragrances (IFF), which was announced last May.

Plant-based strategy: Dean Foods increases investment in flaxseed dairy alternatives brand

04 Jul 2018 --- Dean Foods Company has increased its ownership percentage and taken a majority stake in Good Karma Foods, a US brand known for its flaxseed-based milk and yogurt alternatives. The investment points to Dean Foods' commitment to plant-based foods and beverages at a time when more and more consumers are looking to minimize their consumption of animal-derived products.

Probiotic expansion: General Mills leads investment in GoodBelly parent

21 Jun 2018 --- General Mills' venture arm, 301 Inc., is leading a US$12 million round in funding in NextFoods the parent company of GoodBelly Probiotics. Additional capital is coming from existing investors, including Emil Capital Partners. NextFoods was founded in 2007 by Todd Beckman and Steve Demos, who founded WhiteWave Foods, the owner of Silk plant-based milk.

Probiotics: Scientists investigate how seaweed can give a dietary boost to gut bacteria

11 May 2018 --- US researchers examining how to manipulate gut bacteria to boost essential nutrients for better health have been “blown away” by the results they got when using dietary seaweed in mice.

Nexira enters strategic partnership for nutritionals, not giving up its acquisition plans

02 May 2018 --- Nexira, a global leader in natural and organic ingredients for the food, health and nutrition industries, has announced a strategic partnership agreement with Omega Pharma NV, one of the largest OTC healthcare companies in Europe and Inqpharm Group (a Zaluvida company), a specialty pharmaceutical company.

Clinical merger: Novartis acquires AveXis for US$8.7bn, expands in gene therapy

09 Apr 2018 --- Novartis has entered into an agreement and plan of merger with AveXis, Inc. to acquire the US-based Nasdaq-listed clinical-stage gene therapy company for US$8.7 billion in cash (US$218 per share). The transaction was unanimously approved by the Boards of both companies. The move comes just days after Novartis agreed to sell its stake in a consumer healthcare joint venture for $13 billion to GlaxoSmithKline.

Probi signs agreement with pharma company Cilag on probiotic OTC product

23 Mar 2018 --- Probi has signed a long-term agreement with Cilag, a member of the Johnson & Johnson Family of Companies, for the development of a probiotic product. The rapid growth of the probiotic segment and new exciting research on the importance of human microbiota have increased interest from pharma companies, and their consumer healthcare divisions, in probiotic product development, Probi notes.

Ancient becomes modern: US$103 million investment for bone broth innovator

12 Mar 2018 --- Ancient Nutrition, a bone broth protein and collagen supplement maker, has secured $103 million in funding through strategic minority investment led by VMG Partners. The company, which is the breakthrough pioneer in Bone Broth Protein supplementation that delivers the benefits of “homemade bone broth in a convenient, easy-to-mix form,” revealed a minority investment from VMG Partners, Hillhouse Capital, ICONIQ Capital, and over 100 members of a co-investor network.

Gelita develops controlled soft gelatin capsule fill release

12 Mar 2018 --- Gelita is offering manufacturers of soft gelatin capsules the opportunity to see first hand the complete spectrum of capsule fill release profiles – including the latest addition to Gelita’s pharmaceutical gelatin portfolio: Gelita EC for enteric performance.

Food allergy experiences linked to personality traits, study suggests

02 Mar 2018 --- A new study has observed a link between certain personality traits and the way that the daily challenges that accompany food allergies are experienced by individuals. The personality trait most in conflict with the challenges is “higher openness to experience”. It is hoped that this research may help people who experience allergies – as well as parents and support groups - understand and manage them.

Probiotic boost: Researchers develop novel method of fortifying snacks with probiotics

02 Mar 2018 --- A research team has laid the foundation for a new method that could create probiotic fortified fruit snacks. The technique – developed by researchers at the Universitat Politècnica de València and the Universidade Federal do Ceará – doses apple chunks with probiotic Lactobacillus casei and dries them at high temperatures.

Colpex attains Friend of the Sea certification for omega 3 fish oil

26 Feb 2018 --- 26 Feb 2018 Peruvian company Colpex International has attained Friend of the Sea's certification for fish oil sourced from anchoveta (Engraulis ringens) fished in the South East Pacific Ocean (FAO Area 87). Colpex is a producer of semi-refined, fully refined and concentrated fish oils and among the top 10 Peruvian fish oil exporters. Friend of the Sea's standard for sustainable fish feed, fish meal, fish oil and omega 3 certifies that the oil originates only from fisheries that are compliant with Friend of the Sea’s sustainable fishing requirements (including good fishery management, selective fishing gears and social responsibility) and that a full chain of custody is in place throughout the supply and production chain. 

Consumers want industry to deliver on nutritious food, without compromising on quality: survey

23 Feb 2018 --- Consumers across EMEA want the food and beverage industry to focus on developing healthier, more nutritious food, according to new research commissioned by Ingredion. In fact, 60 percent of respondents said they feel this should be manufacturers’ top priority. However, consumers made it clear that the food industry must ensure that food quality and freshness is not sacrificed as a result. 

Lonza to expand Florida encapsulation capabilities amid product development acceleration

21 Feb 2018 --- Swiss multinational, chemicals and biotechnology company, the Lonza Group is planning to expand its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in North America. The company will install a new Harro Hӧfliger Modu-C MS encapsulation unit (Harro unit) at its integrated product development and manufacturing facility in Tampa, Florida, to strengthen production and bring its products to market faster. 

Dynamic OTC marketplace: Albertsons and Rite Aid merge, Amazon enters the fray

21 Feb 2018 --- Albertsons Companies, one of the US’ largest grocery retailers, and leading drugstore chain Rite Aid Corporation have announced a definitive merger agreement, creating a retail behemoth with US$83 billion in annual revenue. The move is thought to give the integrated company more weight to compete with bigger chains in an industry anxious about the reported entry of Amazon.com.

Natures Crops, De Wit Speciality Oils enter into European distribution partnership for Ahiflower oil

15 Feb 2018 --- Natures Crops International and De Wit Speciality Oils have entered into a distribution agreement for Ahiflower oil in the European dietary supplement marketplace. This alliance is thought to add strategic value for both companies through each company’s leading position in manufacturing and marketing nutraceutical products.

Fermentalg acquires portfolio of omega 3 production patents in bid to strengthen technological position

06 Feb 2018 --- French microalgae supplier Fermentalg has acquired a portfolio of patents to reinforce its intellectual property and industrial and commercial capabilities in the field of omega 3 production. Fermentalg now owns a portfolio of five patents, some of which have already been issued in several countries, to add to its 21 families of active patents already filed. The company has also acquired a number of microalgae strains to add to its bank of over 2,000 strains which is one of the largest in the world.

Consumer health care: Nestle loses interest in Merck's OTC unit 

05 Feb 2018 --- Nestle has pulled out of the bid for Merck’s consumer health unit, leaving the race to buy the maker of Seven Seas vitamins and various other nutritional supplements without its main contender, Reuters reports. The news came a week after Johnson & Johnson withdrew from the race to buy US drugmaker Pfizer’s consumer health business, leaving Nestlé, GlaxoSmithKline and Reckitt Benckiser among the potential bidders. 

Fermentation focus: Naturex and Cura sign distribution agreement for koji fermented minerals

31 Jan 2018 --- Naturex has signed a global distribution agreement via its Open Innovation program (Ingenium) with Ames-based Cura for their Koji Minerals line of fermented minerals for the dietary supplement and functional food markets. This year’s launches based on Koji fermentation are a stand-alone iron with optimal bioavailability and slow release effect (results supported by two clinical studies) and a blend of seven minerals (iron, zinc, copper, manganese, selenium, molybdenum, chromium) particularly suitable for the multi minerals segment, Naturex reports.

Capsugel acquisition boosts Lonza's “record-breaking” 2017 full-year results

31 Jan 2018 --- Swiss multinational, chemicals and biotechnology company, Lonza has exceeded 2017 earning expectations with robust sales and profit growth that is partly down to acquiring Capsugel last summer. Having closed the acquisition on 5 July 2017, Lonza consolidated Capsugel for nearly six months last year, which the company says strengthens its positions as a world leader in pharmaceutical, biotech and specialty ingredients markets. And now Lonza announces it’s “record-breaking” full-year results, hailing 2017 as a “major transformational year” for the company. 

loading